Van Nostrand Robert L
- SEC CIK
- 0001225198
No open-market purchases or sales filed in the past year.
Current role at each company
- SLS SELLAS Life Sciences Group, Inc.Directoras of Jan 9, 2026
- ITCI Intra-Cellular Therapies, Inc.Directoras of Apr 2, 2025
- YTEN YIELD10 Bioscience, Inc.Directoras of Apr 1, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Van Nostrand Robert L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SLS SELLAS Life Sciences Group, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 (view filing) | Jun 12 | 1 day | Van Nostrand Robert LDirector | PPurchase | +10.0K | $1.48 | +$14.8K | +96.2%20.4K after |
ITCI Intra-Cellular Therapies, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 (view filing) | Jun 18 | 3 days | Van Nostrand Robert LDirector | SSale | −20.0K | $75.91 | −$1.52M | −67.4%9.69K after | 2 lots10b5-1 |
| Feb 28, 2024 (view filing) | Feb 27 | 1 day | Van Nostrand Robert LDirector | SSale | −20.0K | $72.93 | −$1.46M | −67.5%9.61K after | 2 lots |
| Apr 19, 2023 (view filing) | Apr 17 | 2 days | Van Nostrand Robert LDirector | SSale | −10.0K | $63.00 | −$630.0K | −51.7%9.35K after | 10b5-1 |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Van Nostrand Robert LDirector | SSale | −30.0K | $57.13 | −$1.71M | −76.8%9.04K after | 2 lots |